Culture Sisters in Psychedelics host inaugural summit in Vancouver this September Upcoming event said to feature powerful female speakers from broad cross-section of practices and expertise Rowan DunneAugust 10, 2022
Canada Optimi Health partners with patient advocate to launch new psilocybin product The company and Hartle will host a virtual press conference scheduled for Wednesday at 1 pm Natalia Buendia CalvilloAugust 9, 2022
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022
Psychedelics PSYC Corp makes successful psychedelic investments Company stock portfolio appreciates significantly since January 2021 Rowan DunneJuly 5, 2022
Psychedelics Mindset Pharma develops patent-pending new technology Company announces development of novel intranasal formulation with promising efficacy Rowan DunneJune 30, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Business HAVN enters psilocybin mushroom supply agreement with Jamaican cannabis producer Green Stripe was one of the first cannabis companies to get established in Jamaica Natalia Buendia CalvilloJune 7, 2022
Business Optimi enters natural psilocybin supply agreement with Filament Health The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton Natalia Buendia CalvilloMay 31, 2022